4-37686227-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001085400.2(RELL1):āc.61G>Cā(p.Ala21Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000867 in 1,580,734 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001085400.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RELL1 | NM_001085400.2 | c.61G>C | p.Ala21Pro | missense_variant | 1/7 | ENST00000454158.7 | NP_001078869.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RELL1 | ENST00000454158.7 | c.61G>C | p.Ala21Pro | missense_variant | 1/7 | 5 | NM_001085400.2 | ENSP00000398778.2 | ||
RELL1 | ENST00000314117.8 | c.61G>C | p.Ala21Pro | missense_variant | 1/7 | 1 | ENSP00000313385.4 |
Frequencies
GnomAD3 genomes AF: 0.000335 AC: 51AN: 152152Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000101 AC: 20AN: 197318Hom.: 0 AF XY: 0.0000450 AC XY: 5AN XY: 111126
GnomAD4 exome AF: 0.0000602 AC: 86AN: 1428474Hom.: 0 Cov.: 31 AF XY: 0.0000605 AC XY: 43AN XY: 710688
GnomAD4 genome AF: 0.000335 AC: 51AN: 152260Hom.: 0 Cov.: 34 AF XY: 0.000296 AC XY: 22AN XY: 74440
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2024 | The c.61G>C (p.A21P) alteration is located in exon 1 (coding exon 1) of the RELL1 gene. This alteration results from a G to C substitution at nucleotide position 61, causing the alanine (A) at amino acid position 21 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at